Shibata, Kanako <br/><br/>
Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.  [electronic resource] 

 -  Clinical and experimental nephrology  Dec 2015 
 - 1107-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1437-7799 
<br/><br/><label>Standard No.: </label>10.1007/s10157-015-1115-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Body Mass Index<br/>Carboplatin--adverse effects<br/>Creatinine--blood<br/>Cross-Sectional Studies<br/>Cystatin C--blood<br/>Drug Combinations<br/>Female<br/>Glomerular Filtration Rate<br/>Humans<br/>Inulin--metabolism<br/>Kidney Function Tests--methods<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Oxonic Acid--adverse effects<br/>Pyridines--adverse effects<br/>Tegafur--adverse effects